January 2024 - Page 7 of 9

SEC Approves New Bitcoin ETFs, in Boon for Crypto Industry

Jan

SEC Approves New Bitcoin ETFs, in Boon for Crypto Industry

Federal regulators on Wednesday approved a new financial product that tracks the price of Bitcoin, a landmark moment for the cryptocurrency industry that proponents hope will increase investment in the technology.The Securities and Exchange Commission authorized 11 applications to offer exchange-traded funds tied to Bitcoin, a potentially simpler way for people to invest in digital assets. Some of the largest financial firms in the world, including the asset managers BlackRock and Fidelity, were approved to offer the products, known as E.T.F.s, which could begin trading as soon as Thursday on traditional platforms like the Nasdaq.The approvals were hailed as a…

‘Gas-Station Heroin’ Sold as Dietary Supplement Alarms Health Officials

Jan

By Jean Thompson

Investments and Business

‘Gas-Station Heroin’ Sold as Dietary Supplement Alarms Health Officials

The young father headed across the parking lot to join the other parents meeting their children’s new preschool teachers. After a few steps, he began sweating and twitching. As the sky reeled, he staggered back to the car, desperate to lie down in the back seat and breathe, hidden by tinted windows.“Did you take something?” his wife, Anne, shouted at him while dialing 911. Eric, 26, had completed rehab earlier in the summer.“The shot! The shot!” he groaned, just before he hit the ground and blacked out.In the emergency room of a nearby hospital in southern New Jersey, doctors tried…

F.D.A. Warned of Mental Side Effects from Asthma Drug, Singulair. Few Were Told.

Jan

By Jean Thompson

Health

F.D.A. Warned of Mental Side Effects from Asthma Drug, Singulair. Few Were Told.

In early 2020, the Food and Drug Administration responded to decades of escalating concerns about a commonly prescribed drug for asthma and allergies by deploying one of its most potent tools: a stark warning on the drug’s label that it could cause aggression, agitation and even suicidal thoughts.The agency’s label, which was primarily aimed at doctors, was supposed to sound an alert about the 25-year-old medication, Singulair, also known by its generic name, montelukast. But it barely dented use: The drug was still prescribed to 12 million people in the United States in 2022.Children face the greatest risks of the…

Jan

By Jean Thompson

Science and Technology

A.I. Giant Tied to China Under Scrutiny

A U.S. congressional committee has asked the Commerce Department to look into whether a giant technology company controlled by the ruling family of the United Arab Emirates should be put under trade restrictions because of its ties to China.The company, G42, specializes in artificial intelligence and other emerging technologies, and is overseen by Sheikh Tahnoon bin Zayed, the national security adviser of the Emirates and a younger brother of the country’s ruler.It has signed recent agreements with prominent American technology companies, including Microsoft, Dell and OpenAI. A Silicon Valley chip firm, Cerebras, is building a supercomputer for G42 to create…

U.S. Steel Acquisition Proposal Tests Biden’s Industrial Policy

Jan

By Jean Thompson

Investments and Business

U.S. Steel Acquisition Proposal Tests Biden’s Industrial Policy

U.S. Steel is an iconic example of the lost manufacturing muscle that President Biden says his economic policies will bring back to the United States.But last month, the storied-but-diminished company announced plans to be acquired by a Japanese competitor. That development has put Mr. Biden in an awkward bind as he tries to balance attempts to revitalize the nation’s industrial sector with his efforts to rebuild international alliances.Mr. Biden’s administration has expressed some discomfort with the deal and is reviewing the proposed $14.1 billion takeover bid by Japan’s Nippon Steel. The company is offering a hefty premium for U.S. Steel,…

Paxlovid Cuts Covid Death Risk. But Those Who Need It Are Not Taking It.

Jan

By Jean Thompson

Health

Paxlovid Cuts Covid Death Risk. But Those Who Need It Are Not Taking It.

As Covid rises again, killing about 1,500 Americans each week, medical researchers are trying to understand why so few people are taking Paxlovid, a medicine that is stunningly effective in preventing severe illness and death from the disease.A study of a million high-risk people with Covid found that only about 15 percent who were eligible for the drug took it. If instead half of the eligible patients in the United States had gotten Paxlovid during the time period of the research, 48,000 deaths could have been prevented, the authors of the study, conducted by the National Institutes of Health, concluded.It’s…